Att B - 60d FRN

sradovich on DSK3TPTVN1PROD with NOTICES

Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices
Committee (Committee or DAC). The
meeting is open to the public. During
this meeting, members of the Committee
will receive and discuss summaries of
activities and recommendations from its
subcommittees.
DATES: The Committee’s next meeting
will take place on Thursday, June 16,
2016, from 9:00 a.m. to 3:30 p.m. (EST).
ADDRESSES: Federal Communications
Commission, 445 12th Street SW.,
Washington, DC 20554, in the
Commission Meeting Room.
FOR FURTHER INFORMATION CONTACT:
Elaine Gardner, Consumer and
Governmental Affairs Bureau: 202–418–
0581 (voice); email: [email protected]; or
Suzy Rosen Singleton, Alternate DAC
Designated Federal Officer, Consumer
and Governmental Affairs Bureau: 202–
510–9446 (VP/voice), at the same email
address: [email protected].
SUPPLEMENTARY INFORMATION: The
Committee was established in December
2014 to make recommendations to the
Commission on a wide array of
disability matters within the jurisdiction
of the Commission, and to facilitate the
participation of people with disabilities
in proceedings before the Commission.
The Committee is organized under, and
operated in accordance with, the
provisions of the Federal Advisory
Committee Act (FACA). The Committee
held its first meeting on March 17, 2015.
At its June 16, 2016 meeting, the
Committee is expected to receive and
consider a report on the activities of its
Communications Subcommittee; a
report and recommendation from its
Emergency Communications
Subcommittee regarding proposed DAC
comments on the Commission’s Notice
of Proposed Rulemaking on Wireless
Emergency Alerts; a report on the
activities of its Relay & Equipment
Distribution Subcommittee; a report and
recommendation from its Technology
Transitions Subcommittee regarding the
benefits of HD Voice and ways to
address the transition to HD Voice; and
a report and possible recommendation
from its Video Programming
Subcommittee regarding appropriate
capitalization of offline captioning of
video programming. The Committee
will also (1) hear presentations from
Commission staff on recent activities;
(2) hear reports from various FCC
bureaus, including: A report from the
FCC Wireline Competition Bureau on
the modernization of the Lifeline
program; a report from FCC Media
Bureau on the commercial availability
of set top boxes and the expansion of
video description; and an update on the
ACE Direct project; and (3) discuss new
issues for its consideration.

VerDate Sep<11>2014

20:07 May 27, 2016

Jkt 238001

A limited amount of time may be
available on the agenda for comments
and inquiries from the public. The
public may comment or ask questions of
presenters via the email address
[email protected].
The meeting site is fully accessible to
people using wheelchairs or other
mobility aids. Sign language
interpreters, open captioning, and
assistive listening devices will be
provided on site. Other reasonable
accommodations for people with
disabilities are available upon request. If
making a request for an accommodation,
please include a description of the
accommodation you will need and tell
us how to contact you if we need more
information. Make your request as early
as possible by sending an email to
[email protected] or calling the Consumer
and Governmental Affairs Bureau at
202–418–0530 (voice), 202–418–0432
(TTY). Last minute requests will be
accepted, but may be impossible to fill.
The meeting will be webcast with open
captioning, at: www.fcc.gov/live.
To request materials in accessible
formats for people with disabilities
(Braille, large print, electronic files,
audio format), send an email to fcc504@
fcc.gov or call the Consumer and
Governmental Affairs Bureau at (202)
418–0530 (voice), (202) 418–0432
(TTY).

34337

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–16–0666; Docket No. CDC–2016–
0046]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on the National Healthcare
Safety Network (NHSN). NHSN is a
system designed to accumulate,
exchange, and integrate relevant
information and resources among
private and public stakeholders to
support local and national efforts to
protect patients and promote healthcare
Federal Communications Commission.
safety.
Karen Peltz Strauss,
DATES: Written comments must be
received on or before August 1, 2016.
Deputy Chief, Consumer and Governmental
Affairs Bureau.
ADDRESSES: You may submit comments,
[FR Doc. 2016–12710 Filed 5–27–16; 8:45 am]
identified by Docket No. CDC–2016–
BILLING CODE 6712–01–P
0046 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
FEDERAL ELECTION COMMISSION
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Sunshine Act Meetings
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
AGENCY: Federal Election Commission
D74, Atlanta, Georgia 30329.
DATE & TIME: Thursday, May 26, 2016 At
Instructions: All submissions received
10:00 a.m.
must include the agency name and
PLACE: 999 E Street NW., Washington,
Docket Number. All relevant comments
DC (Ninth Floor)
received will be posted without change
STATUS: This meeting will be open to the to Regulations.gov, including any
personal information provided. For
public.
access to the docket to read background
Federal Register Notice of Previous
documents or comments received, go to
Anouncement—81 FR 32753
Regulations.gov.
CHANGE IN THE MEETING: The May 26,
Please note: All public comment should be
2016 meeting was cancelled.
submitted through the Federal eRulemaking
PERSON TO CONTACT FOR INFORMATION:
portal (Regulations.gov) or by U.S. mail to the
Judith Ingram, Press Officer, Telephone: address listed above.
(202) 694–1220.
FOR FURTHER INFORMATION CONTACT: To
Shelley E. Garr,
request more information on the
Deputy Secretary of the Commission.
proposed project or to obtain a copy of
[FR Doc. 2016–12820 Filed 5–26–16; 11:15 am]
the information collection plan and
instruments, contact the Information
BILLING CODE 6715–01–P

PO 00000

Frm 00029

Fmt 4703

Sfmt 4703

SUMMARY:

E:\FR\FM\31MYN1.SGM

31MYN1

34338

Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices

Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial

Biovigilance, Long-Term Care Facility
(LTCF), and Dialysis. The Outpatient
Procedure Component is on track to be
released in NHSN in 2017/2018. The
development of this component has
been previously delayed to obtain
additional user feedback and support
from outside partners.
Changes were made to six facility
surveys and two new facility surveys
were added. Based on user feedback and
internal reviews of the annual facility
surveys it was determined that
questions and response options be
amended, removed, or added to fit the
evolving uses of the annual facility
surveys. The surveys are being
increasingly used to help intelligently
interpret the other data elements
reported into NHSN. Currently the
surveys are used to appropriately risk
adjust the numerator and denominator
data entered into NHSN while also
guiding decisions on future division
priorities for prevention.
Further, three new forms were added
to expand NHSN surveillance to
pediatric ventilator-associated events,
adult sepsis, and custom HAI event
surveillance. An additional 14 forms
were added to the Hemovigilance
Component to streamline data
collection/entry for adverse reaction
events.
Additionally, minor revisions have
been made to 22 forms within the
package to clarify and/or update
surveillance definitions. The previously
approved NHSN package included 52
individual collection forms; the current
revision request adds nineteen forms
and removes one form for a total of 70
forms. The reporting burden will
increase by 489,174 hours, for a total of
5,110,716 hours.

resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
National Healthcare Safety Network
(NHSN)—Revision—National Center for
Emerging and Zoonotic Infection
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The National Healthcare Safety
Network (NHSN) is a system designed to
accumulate, exchange, and integrate
relevant information and resources
among private and public stakeholders
to support local and national efforts to
protect patients and promote healthcare
safety. Specifically, the data is used to
determine the magnitude of various
healthcare-associated adverse events
and trends in the rates of these events
among patients and healthcare workers
with similar risks. The data will be used
to detect changes in the epidemiology of
adverse events resulting from new and
current medical therapies and changing
risks. The NHSN currently consists of
five components: Patient Safety,
Healthcare Personnel Safety,

ESTIMATED ANNUALIZED BURDEN HOURS

sradovich on DSK3TPTVN1PROD with NOTICES

Type of respondents
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).

VerDate Sep<11>2014

Number of
respondents

Form name

Number of
responses per
Respondent

Avg. burden
per response
(in hrs.)

Total burden
(in hrs.)

(Infection

57.100 NHSN Registration Form .....

2,000

1

5/60

167

(Infection

57.101 Facility Contact Information

2,000

1

10/60

333

(Infection

57.103 Patient Safety Component—
Annual Hospital Survey.
57.105 Group Contact Information ..

5,000

1

55/60

4,583

1,000

1

5/60

83

6,000

12

15/60

18,000

6,000

44

30/60

132,000

(Infection

57.106 Patient Safety Monthly Reporting Plan.
57.108 Primary Bloodstream Infection (BSI).
57.111 Pneumonia (PNEU) .............

6,000

72

30/60

216,000

(Infection

57.112 Ventilator-Associated Event

6,000

144

25/60

360,000

(Infection

57.113 Pediatric Ventilator-Associated Event (PedVAE).

2,000

120

25/60

100,000

(Infection
(Infection
(Infection

20:07 May 27, 2016

Jkt 238001

PO 00000

Frm 00030

Fmt 4703

Sfmt 4703

E:\FR\FM\31MYN1.SGM

31MYN1

34339

Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
Respondent

Avg. burden
per response
(in hrs.)

Total burden
(in hrs.)

Form name

Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Staff RN .............................................

57.114 Urinary Tract Infection (UTI)

6,000

40

20/60

80,000

57.115 Custom Event ......................

2,000

91

35/60

106,167

57.116 Denominators for Neonatal
Intensive Care Unit (NICU).
57.117 Denominators for Specialty
Care
Area
(SCA)/Oncology
(ONC).
57.118 Denominators for Intensive
Care Unit (ICU)/Other locations
(not NICU or SCA).
57.120 Surgical Site Infection (SSI)

6,000

9

3

162,000

6,000

9

5

270,000

6,000

60

5

1,800,000

6,000

36

35/60

126,000

57.121 Denominator for Procedure
57.123 Antimicrobial Use and Resistance (AUR)-Microbiology Data
Electronic Upload Specification
Tables.
57.124 Antimicrobial Use and Resistance (AUR)-Pharmacy Data
Electronic Upload Specification
Tables.
57.125 Central Line Insertion Practices Adherence Monitoring.
57.126 MDRO or CDI Infection
Form.
57.127 MDRO and CDI Prevention
Process and Outcome Measures
Monthly Monitoring.
57.128 Laboratory-identified MDRO
or CDI Event.
57.129 Adult Sepsis .........................

6,000
6,000

540
12

10/60
5/60

540,000
6,000

6,000

12

5/60

6,000

1,000

100

25/60

41,667

6,000

72

30/60

216,000

6,000

24

15/60

36,000

6,000

240

20/60

480,000

50

250

25/60

5,208

57.137 Long-Term Care Facility
Component—Annual Facility Survey.
57.138 Laboratory-identified MDRO
or CDI Event for LTCF.
57.139 MDRO and CDI Prevention
Process Measures Monthly Monitoring for LTCF.
57.140 Urinary Tract Infection (UTI)
for LTCF.
57.141 Monthly Reporting Plan for
LTCF.
57.142 Denominators for LTCF Locations.
57.143 Prevention Process Measures Monthly Monitoring for LTCF.
57.150 LTAC Annual Survey ...........

350

1

1.08

378

350

12

15/60

1,050

350

12

10/60

700

350

14

30/60

2,450

350

12

5/60

350

350

12

3.35

14,070

300

12

5/60

300

400

1

55/60

367

57.151 Rehab Annual Survey .........

1,000

1

55/60

917

57.200 Healthcare Personnel Safety
Component Annual Facility Survey.
57.203 Healthcare Personnel Safety
Monthly Reporting Plan.
57.204 Healthcare Worker Demographic Data.
57.205 Exposure to Blood/Body
Fluids.
57.206 Healthcare Worker Prophylaxis/Treatment.
57.207 Follow-Up Laboratory Testing.
57.210 Healthcare Worker Prophylaxis/Treatment-Influenza.

50

1

8

400

17,000

1

5/60

1,417

50

200

20/60

3,333

50

50

1

2,500

50

30

15/60

375

50

50

15/60

625

50

50

10/60

417

Staff RN .............................................
Staff RN .............................................
Registered
Nurse
(Infection
Preventionist).
Staff RN .............................................
Laboratory Technician .......................

Pharmacist .........................................

Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).

(Infection

Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).

(Infection

Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).

(Infection

(Infection
(Infection

(Infection
(Infection

(Infection

Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Occupational Health RN/Specialist ...
Occupational Health RN/Specialist ...
Occupational Health RN/Specialist ...
sradovich on DSK3TPTVN1PROD with NOTICES

Number of
respondents

Type of respondents

Occupational Health RN/Specialist ...
Occupational Health RN/Specialist ...
Laboratory Technician .......................
Occupational Health RN/Specialist ...

VerDate Sep<11>2014

20:07 May 27, 2016

Jkt 238001

PO 00000

Frm 00031

Fmt 4703

Sfmt 4703

E:\FR\FM\31MYN1.SGM

31MYN1

34340

Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued

Type of respondents
Medical/Clinical
nologist.
Medical/Clinical
nologist.
Medical/Clinical
nologist.
Medical/Clinical
nologist.
Medical/Clinical
nologist.

Laboratory

Tech-

Laboratory

Tech-

Laboratory

Tech-

Laboratory

Tech-

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Medical/Clinical
nologist.
Medical/Clinical
nologist.
Medical/Clinical
nologist.

Laboratory

Tech-

Laboratory

Tech-

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Medical/Clinical
nologist.

Laboratory

Tech-

Staff RN .............................................
Staff RN .............................................

sradovich on DSK3TPTVN1PROD with NOTICES

Staff RN .............................................

Staff RN .............................................
Registered
Nurse
(Infection
Preventionist).
Staff RN .............................................
Staff RN .............................................

VerDate Sep<11>2014

20:07 May 27, 2016

Number of
respondents

Form name
57.300 Hemovigilance Module Annual Survey.
57.301
Hemovigilance
Module
Monthly Reporting Plan.
57.303
Hemovigilance
Module
Monthly Reporting Denominators.
57.305 Hemovigilance Incident .......
57.306 Hemovigilance Module Annual Survey—Non-acute care facility.
57.307 Hemovigilance Adverse Reaction—Acute Hemolytic Transfusion Reaction.
57.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction.
57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction.
57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction.
57.311 Hemovigilance Adverse Reaction—Febrile
Non-hemolytic
Transfusion Reaction.
57.312 Hemovigilance Adverse Reaction—Hypotensive Transfusion
Reaction.
57.313 Hemovigilance Adverse Reaction—Infection.
57.314 Hemovigilance Adverse Reaction—Post Transfusion Purpura.
57.315 Hemovigilance Adverse Reaction—Transfusion
Associated
Dyspnea.
57.316 Hemovigilance Adverse Reaction—Transfusion
Associated
Graft vs. Host Disease.
57.317 Hemovigilance Adverse Reaction—Transfusion
Related
Acute Lung Injury.
57.318 Hemovigilance Adverse Reaction—Transfusion
Associated
Circulatory Overload.
57.319 Hemovigilance Adverse Reaction—Unknown
Transfusion
Reaction.
57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction.
57.400 Patient Safety Component—
Annual Facility Survey for Ambulatory Surgery Center (ASC).
57.401 Outpatient Procedure Component—Monthly Reporting Plan.
57.402 Outpatient Procedure Component Event.
57.403 Outpatient Procedure Component—Monthly
Denominators
and Summary.
57.500 Outpatient Dialysis Center
Practices Survey.
57.501 Dialysis Monthly Reporting
Plan.
57.502 Dialysis Event ......................
57.503 Denominator for Outpatient
Dialysis.

Jkt 238001

PO 00000

Frm 00032

Fmt 4703

Sfmt 4703

Number of
responses per
Respondent

Avg. burden
per response
(in hrs.)

Total burden
(in hrs.)

500

1

2

1,000

500

12

1/60

100

500

12

1.17

7,020

500

10

10/60

833

200

1

35/60

117

500

4

25/60

833

500

4

25/60

833

500

1

25/60

208

500

2

25/60

417

500

4

25/60

833

500

1

25/60

208

500

1

25/60

208

500

1

25/60

208

500

1

25/60

208

500

1

25/60

208

500

1

25/60

208

500

2

25/60

417

500

1

25/60

208

500

1

25/60

208

5,000

1

5/60

417

5,000

12

15/60

15,000

5,000

25

40/60

83,333

5,000

12

40/60

40,000

6,500

1

2.0

13,000

6,500

12

5/60

6,500

6,500
6,500

60
12

25/60
10/60

162,500
13,000

E:\FR\FM\31MYN1.SGM

31MYN1

34341

Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name

Staff RN .............................................

57.504 Prevention Process Measures Monthly Monitoring for Dialysis.
57.505 Dialysis Patient Influenza
Vaccination.
57.506 Dialysis Patient Influenza
Vaccination Denominator.
57.507 Home Dialysis Center Practices Survey.
..........................................................

Staff RN .............................................
Staff RN .............................................
Staff RN .............................................
Total ...................................................

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–12701 Filed 5–27–16; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-16–16TM]

Agency Forms Undergoing Paperwork
Reduction Act Review

sradovich on DSK3TPTVN1PROD with NOTICES

Number of
respondents

Type of respondents

The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through

VerDate Sep<11>2014

20:07 May 27, 2016

Jkt 238001

1.25

22,500

325

75

10/60

4,063

325

5

10/60

271

600

1

25/60

250

5,110,716

Background and Brief Description
Preventing healthcare-associated
infections (HAI) and encouraging
appropriate use of antimicrobials are
priorities of both the U.S. Department of
Health and Human Services and the
Centers for Disease Control and
Prevention. The burden and
epidemiology of HAIs and antimicrobial
use in U.S. nursing homes is currently
unknown. Understanding the scope and
magnitude of all types of HAIs in
patient populations across the spectrum
of U.S. healthcare facilities is essential
to the development of effective
prevention and control strategies and
policies.
HAI prevalence and antimicrobial use
estimates can be obtained through
prevalence surveys in which data are

Fmt 4703

Sfmt 4703

Total burden
(in hrs.)

12

Proposed Project
Prevalence Survey of HealthcareAssociated Infections and Antimicrobial
Use in U.S. Nursing Homes—New—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).

Frm 00033

Avg. burden
per response
(in hrs.)

1,500

the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to [email protected]. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.

PO 00000

Number of
responses per
Respondent

collected in healthcare facilities during
a short, specified time period. Essential
steps in reducing the occurrence of
HAIs and the prevalence of resistant
pathogens include estimating the
burden, types, and causative organisms
of HAIs; assessing the nature and extent
of antimicrobial use in U.S. healthcare
facilities; and assessing the nature and
extent of antimicrobial use.
Prevalence surveys, in which data are
collected in healthcare facilities during
a short, specified time period represent
an efficient and cost-effective alternative
to prospective studies of HAI and
antimicrobial use incidence. Given the
absence of existing HAI and
antimicrobial use data collection
mechanisms for nursing homes,
prevalence surveys represent a robust
method for obtaining the surveillance
data required to identify HAIs and
antibiotic use practices that should be
targeted for more intensive surveillance
and to guide and evaluate prevention
efforts.
The methods for the data collection
are based on those used in CDC hospital
prevalence surveys and informed by a
CDC pilot survey conducted in nine
U.S. nursing homes. The survey will be
performed by the CDC through the
Emerging Infections Program (EIP), a
collaboration with CDC and 10 state
health departments with experience in
HAI surveillance and data collection.
Respondents are nursing homes
certified by the Centers for Medicare &
Medicare Services in EIP states. Nursing
homes will be randomly selected for
participation. The EIP will recruit 20
nursing homes in each of the 10 EIP
sites. Nursing home participation is
voluntary.
OMB approval is requested for three
years. Participation is voluntary and
there are no costs to respondents other
than their time. The total estimated
annual burden hours are 5,217.

E:\FR\FM\31MYN1.SGM

31MYN1